Nørgård B, Fonager K, Sørensen H T, Olsen J
The Danish Epidemiology Science Centre and the Department of Epidemiology and Social Medicine, University of Aarhus.
Am J Gastroenterol. 1999 Sep;94(9):2435-40. doi: 10.1111/j.1572-0241.1999.01370.x.
We aimed to examine birthweight, low birthweight (<2500 g), and intrauterine growth retardation in offspring of women with celiac disease in relation to their first hospitalization for the disease.
This was a historical cohort study based on The Danish Medical Birth Registry data of celiac women discharged from Danish hospitals from 1977-1992. The study included 211 newborns to 127 mothers with celiac disease, and 1260 control deliveries.
Before celiac women were first hospitalized the mean birthweight of their newborns was 238 g (95% confidence interval [95% CI] = 150, 325 g) lower than that of the control women, after adjustment for potential confounders. After the first hospitalization the mean birthweight for newborns of diseased women was higher than that of controls, by 67 g (95% CI = -88, 223 g) after adjustment for potential confounders. Before celiac women were first hospitalized we found an increased risk of low birthweight (odds ratio [OR] = 2.6, 95% CI = 1.3-5.5) and intrauterine growth retardation (OR = 3.4, 95% CI = 1.6-7.2). After celiac women were first hospitalized we found no increased risk of low birthweight and no babies with intrauterine growth retardation.
Offspring of mothers with celiac disease had lower birthweight than expected and more than a three-fold higher risk of intrauterine growth retardation when birth occurred before the first hospitalization for the disease. After the mother's first hospitalization the birthweight was similar to controls and no increased risk of low birthweight was seen. Our study indicates that treatment of celiac women is important in the prevention of fetal growth retardation.
我们旨在研究患有乳糜泻的女性的后代的出生体重、低出生体重(<2500克)和宫内生长迟缓情况,并将其与首次因该疾病住院治疗相关联。
这是一项基于丹麦医疗出生登记处数据的历史性队列研究,数据来源于1977年至1992年从丹麦医院出院的乳糜泻女性。该研究纳入了127名患有乳糜泻的母亲所生的211名新生儿,以及1260例对照分娩。
在乳糜泻女性首次住院前,经潜在混杂因素调整后,其新生儿的平均出生体重比对照女性低238克(95%置信区间[95%CI]=150,325克)。首次住院后,经潜在混杂因素调整后,患病女性新生儿的平均出生体重比对照高67克(95%CI=-88,223克)。在乳糜泻女性首次住院前,我们发现低出生体重风险增加(比值比[OR]=2.6,95%CI=1.3-5.5)以及宫内生长迟缓风险增加(OR=3.4,95%CI=1.6-7.2)。在乳糜泻女性首次住院后,我们未发现低出生体重风险增加,也没有出现宫内生长迟缓的婴儿。
患有乳糜泻的母亲的后代在母亲首次因该疾病住院前出生时,出生体重低于预期,且宫内生长迟缓风险高出三倍多。母亲首次住院后,出生体重与对照相似,未发现低出生体重风险增加。我们的研究表明,对乳糜泻女性进行治疗对于预防胎儿生长迟缓很重要。